Carl Janssen is the Pfizer Oncology Country Lead in Germany. He is a member of the leadership team in Germany as well as the Oncology Leadership Team in Europe. Carl joined Pfizer in the Netherlands as Medical Director in 1998. Carl was appointed Oncology Business Unit Head in the Netherlands in September 2009. In March 2013, he started leading a cluster of countries (Netherlands, Nordics and later also the Baltic States and Belarus). He moved to Berlin to lead the Oncology Team in Germany on October 1, 2015
From Big to Smart Data in Health Care and Pharmaceutical Industry
When and if we will turn Big Data into Smart Data the impact on Health Care and Pharmaceutical Medicine can be profound. Examples of current and future developments will be discussed, focusing on personalized medicine in oncology.
- IMPACT Session III: How Big Data will disrupt business models on November 21, 2017 10:45 am